an increase in mitoxantrone dose to 12 mg/m2/d produced complete remissions in 8 of 19 evaluable patients with acute nonlymphoblastic leukemia , in one of ten patients with refractory acute nonlymphoblastic leukemia , and in one of four patients with chronic granulocytic leukemia in blast crisis .
C0026259
mitoxantrone
C0023467
acute nonlymphoblastic leukemia